ICCC
#3958
ImmuCell Corporation - Common Stock
11.7 2 USD
+0.06%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+5.78%
Monthly Change
+23.11%
6 month change
+72.61%
Year Change
+84.86%
Previous Close
11.0 8
Open
11.7 2
Low
11.7 2
High
11.7 2
Volume
5
Financials
- Market Capitalization 106.03 M
- Employee 73
- Founded 1982
- CEO Michael F Brigham
- Website www.immucell.com
- Headquarter Delaware, United States
- FIGI BBG000BLQ5Q2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-51.25
Price to sales ratio
2.01
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3946 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.55 USD | +2.94% | -6.76% | +3.41% | -55.52% | 108.25 M USD | ||
| 3955 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.86 USD | -2.11% | -8.82% | +7.51% | -36.95% | 106.58 M USD | ||
| 3976 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.93 USD | +0.17% | -1.33% | +1.72% | -1.50% | 101.87 M USD | ||
| 3989 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.70 USD | -22.02% | -20.56% | -42.37% | -31.73% | 98.43 M USD |
Frequently asked questions about ImmuCell Corporation - Common Stock
What is the ImmuCell Corporation - Common Stock stock price today?
The current price of ImmuCell Corporation - Common Stock (ICCC) is 11.72. Over the past 24 hours, the stock has changed by +5.78%. Follow the ICCC chart for real-time price dynamics.
What is the stock ticker of ImmuCell Corporation - Common Stock?
ImmuCell Corporation - Common Stock trades under the ticker ICCC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ImmuCell Corporation - Common Stock stock going up?
ICCC has changed by +11.73% over the last week, +23.11% over the last month, and +84.86% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was ImmuCell Corporation - Common Stock net income for the last quarter?
ImmuCell Corporation - Common Stock reported net income of 1.94 M for the last quarter. The previous quarter showed -2.85 M, which means net income changed by +168.15%.
How many employees does ImmuCell Corporation - Common Stock have?
As of the latest available data, ImmuCell Corporation - Common Stock has 73 employees. Workforce size can provide additional context about the company's scale and operations.
What is ImmuCell Corporation - Common Stock EBITDA?
ImmuCell Corporation - Common Stock EBITDA is 2.5 M, and its EBITDA margin is 24.14%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ImmuCell Corporation - Common Stock stock?
You can buy ImmuCell Corporation - Common Stock (ICCC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ImmuCell Corporation - Common Stock stock?
Investing in ImmuCell Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ICCC chart and related analysis on metatrader.com as part of your research.